Down -57.53% in 4 Weeks, Here's Why Fulcrum Therapeutics (FULC) Looks Ripe for a Turnaround
Fulcrum Therapeutics(FULC) ZACKS·2024-10-04 14:36
A downtrend has been apparent in Fulcrum Therapeutics, Inc. (FULC) lately with too much selling pressure. The stock has declined 57.5% over the past four weeks. However, given the fact that it is now in oversold territory and Wall Street analysts are majorly in agreement about the company's ability to report better earnings than they predicted earlier, the stock could be due for a turnaround. Here is How to Spot Oversold Stocks We use Relative Strength Index (RSI), one of the most commonly used technical in ...